What are the differences in acute and subacute sensitivities on a routine brain Magnetic Resonance Imaging (MRI) and how can a radiologist determine fluid sensitivities on different weighted sequences, such as T1-weighted, T2-weighted, and Fluid Attenuated Inversion Recovery (FLAIR) sequences?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 7, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

MRI Signal Characteristics for Acute and Subacute Hemorrhage Detection

Radiologists determine fluid sensitivities on routine brain MRI by recognizing that T2-weighted FLAIR sequences are superior for detecting subacute hemorrhage (showing extracellular methemoglobin as high signal), while T2 gradient-echo (GRE) and susceptibility-weighted imaging (SWI) are significantly more sensitive than CT for detecting both subacute and chronic hemorrhage across all stages.* 1

Key Sequence-Specific Sensitivities

Acute Hemorrhage Detection (< 1 week)

  • T2 GRE sequences* are equivalent to non-contrast CT in detecting acute intracranial hemorrhage 1
  • CT remains highly sensitive for acute hemorrhage detection at 98% sensitivity and 99% specificity, particularly within the first week when blood appears hyperdense (high Hounsfield values) 1
  • Gradient-echo sequences detect the artery susceptibility sign (MR correlate of hyperdense vessel) in 82% of cases versus 54% with CT 2

Subacute Hemorrhage Detection (1 week to 2 months)

  • T2-weighted and T2-weighted FLAIR sequences are more sensitive than CT for detecting subacute subarachnoid hemorrhage, small subdural hematomas, brain contusions, and brainstem injuries 1
  • FLAIR sequences should ideally be performed within 2 weeks of symptom onset to demonstrate extracellular methemoglobin, which appears as high signal on both T1- and T2-weighted sequences 1
  • Modern T2-weighted FLAIR techniques are comparable with or more sensitive than CT for all stages of subarachnoid hemorrhage 1
  • T2 GRE is significantly more sensitive* than CT for detecting subacute and chronic hemorrhage (evidence levels Ib-II) 1

Practical Algorithm for Fluid Sensitivity Determination

Step 1: Timing-Based Sequence Selection

  • Within 1 week of clinical event: Use CT or T2* GRE for acute blood detection 1
  • 1-2 weeks post-event: FLAIR sequences optimally detect extracellular methemoglobin 1
  • Beyond 2 weeks: Follow-up MRI at 2 months to confirm resolution of signal changes indicative of recent hemorrhage 1

Step 2: Sequence-Specific Signal Interpretation

T1-Weighted Sequences:

  • Provide superior grey matter-white matter contrast-to-noise ratios 3
  • T1-weighted FLAIR offers improved lesion-to-background contrast compared to conventional T1-weighted FSE 3

T2-Weighted FLAIR:

  • Suppresses CSF signal while maintaining T2-weighted contrast, making it superior for detecting lesions adjacent to CSF spaces 4
  • Achieves 9% overall error rate in characterizing cystic lesions versus 22% for T1-weighted and 27% for T2-weighted sequences 4
  • Shows higher signal intensity difference between pathologic lesions and CSF compared to conventional sequences 4
  • Demonstrates 85% sensitivity for infectious leptomeningitis with 93% specificity when used without contrast 5

T2 GRE and SWI:*

  • SWI is 3-6 times more sensitive than T2* GRE in detecting hemorrhagic axonal injuries in moderate to severe TBI 1
  • Both sequences exploit paramagnetic properties of blood products and deoxyhemoglobin 1
  • Detect microhemorrhages with far greater sensitivity than CT across all hemorrhage stages 1

Step 3: Comparative Signal Analysis

For distinguishing free water-like versus non-free water-like fluid:

  • Calculate the ratio of signal intensity between the lesion and CSF on FLAIR and proton density-weighted sequences 4
  • FLAIR imaging provides the highest signal intensity difference between cystic lesions and CSF, improving distinction between neoplastic/inflammatory versus maldevelopmental/porencephalic lesions 4

Critical Pitfalls to Avoid

FLAIR-Specific Artifacts

  • Propofol and supplemental oxygen can artifactually increase sulcal signal on FLAIR sequences in children, mimicking subarachnoid hemorrhage 1
  • Meningitis can produce similar sulcal hyperintensity patterns 1
  • Scanner-specific left-right intensity asymmetries exist on FLAIR and T1-weighted images, creating diagnostic uncertainty in 62.5% of cases with >10% asymmetry 6

Timing-Dependent Limitations

  • Hemosiderin halo alone or solely an increase in lesion diameter on GRE without evidence of recent hemorrhage on timely imaging does not constitute acute/subacute hemorrhage 1
  • DWI is superior to FLAIR for acute ischemic changes, with FLAIR being relatively insensitive to acute ischemia compared to DWI 2
  • T2 "shine-through" effect on DWI requires ADC map correlation to increase specificity 2

Sequence Selection Errors

  • Conventional T1- and T2-weighted sequences inaccurately characterize keratin-containing cysts and pineal cysts 4
  • Contrast enhancement does not improve conspicuity of acute brain injury in traumatic brain injury 1
  • Vascular hyperintensities on FLAIR may represent slow-flowing blood through collaterals rather than parenchymal pathology 2

Enhanced Detection Strategies

  • Susceptibility-weighted imaging reliably detects intracranial hemorrhage, allowing MRI as the sole initial imaging modality for acute stroke evaluation 2
  • Streamlined MRI protocols including DWI, FLAIR, gradient-echo, and perfusion can be completed in approximately 10 minutes, competitive with CT acquisition times 2
  • FLAIR increases MRI yield by 30% in epilepsy patients, detecting lesions in hippocampus, amygdala, cortex, and periventricular regions not visible on conventional sequences 7

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.